These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. Ghaleiha A; Entezari N; Modabbernia A; Najand B; Askari N; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S J Psychiatr Res; 2013 Feb; 47(2):175-80. PubMed ID: 23063327 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Sayyah M; Boostani H; Pakseresht S; Malaieri A Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1513-6. PubMed ID: 19737592 [TBL] [Abstract][Full Text] [Related]
11. Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial. Mowla A; Ghaedsharaf M CNS Spectr; 2020 Aug; 25(4):552-556. PubMed ID: 31648655 [TBL] [Abstract][Full Text] [Related]
12. Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial of efficacy and safety. Alijaniha F; Naseri M; Afsharypuor S; Fallahi F; Noorbala A; Mosaddegh M; Faghihzadeh S; Sadrai S J Ethnopharmacol; 2015 Apr; 164():378-84. PubMed ID: 25680840 [TBL] [Abstract][Full Text] [Related]
13. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia. Herrera-Arellano A; Luna-Villegas G; Cuevas-Uriostegui ML; Alvarez L; Vargas-Pineda G; Zamilpa-Alvarez A; Tortoriello J Planta Med; 2001 Nov; 67(8):695-9. PubMed ID: 11731907 [TBL] [Abstract][Full Text] [Related]
14. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder. Soltani F; Sayyah M; Feizy F; Malayeri A; Siahpoosh A; Motlagh I Hum Psychopharmacol; 2010 Aug; 25(6):509-13. PubMed ID: 20737524 [TBL] [Abstract][Full Text] [Related]
16. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Akhondzadeh Basti A; Moshiri E; Noorbala AA; Jamshidi AH; Abbasi SH; Akhondzadeh S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):439-42. PubMed ID: 17174460 [TBL] [Abstract][Full Text] [Related]
17. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Sayyah M; Boostani H; Pakseresht S; Malayeri A Psychiatry Res; 2011 Oct; 189(3):403-6. PubMed ID: 21329988 [TBL] [Abstract][Full Text] [Related]
18. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869 [TBL] [Abstract][Full Text] [Related]
19. Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice. Oliva I; González-Trujano ME; Arrieta J; Enciso-Rodríguez R; Navarrete A Phytother Res; 2004 Apr; 18(4):290-6. PubMed ID: 15162363 [TBL] [Abstract][Full Text] [Related]
20. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]